Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Related structures:
AlphaFold database: Q4QIA4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 131 | 135 | PF00656 | 0.583 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.412 |
CLV_NRD_NRD_1 | 275 | 277 | PF00675 | 0.540 |
CLV_NRD_NRD_1 | 70 | 72 | PF00675 | 0.346 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.662 |
CLV_PCSK_FUR_1 | 95 | 99 | PF00082 | 0.525 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.432 |
CLV_PCSK_KEX2_1 | 275 | 277 | PF00082 | 0.540 |
CLV_PCSK_KEX2_1 | 70 | 72 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 97 | 99 | PF00082 | 0.662 |
CLV_PCSK_SKI1_1 | 219 | 223 | PF00082 | 0.589 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.369 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.511 |
DOC_CYCLIN_yCln2_LP_2 | 8 | 14 | PF00134 | 0.391 |
DOC_MAPK_gen_1 | 24 | 30 | PF00069 | 0.256 |
DOC_PP2B_LxvP_1 | 8 | 11 | PF13499 | 0.391 |
DOC_PP4_MxPP_1 | 163 | 166 | PF00568 | 0.528 |
DOC_USP7_MATH_1 | 114 | 118 | PF00917 | 0.620 |
DOC_USP7_MATH_1 | 263 | 267 | PF00917 | 0.571 |
DOC_WW_Pin1_4 | 196 | 201 | PF00397 | 0.675 |
DOC_WW_Pin1_4 | 245 | 250 | PF00397 | 0.678 |
LIG_14-3-3_CanoR_1 | 83 | 93 | PF00244 | 0.517 |
LIG_Actin_WH2_2 | 46 | 61 | PF00022 | 0.256 |
LIG_FHA_1 | 170 | 176 | PF00498 | 0.654 |
LIG_FHA_1 | 184 | 190 | PF00498 | 0.543 |
LIG_FHA_1 | 211 | 217 | PF00498 | 0.630 |
LIG_FHA_1 | 225 | 231 | PF00498 | 0.584 |
LIG_FHA_1 | 45 | 51 | PF00498 | 0.375 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.512 |
LIG_FHA_2 | 1 | 7 | PF00498 | 0.432 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.582 |
LIG_FHA_2 | 186 | 192 | PF00498 | 0.680 |
LIG_FHA_2 | 44 | 50 | PF00498 | 0.323 |
LIG_Integrin_RGD_1 | 159 | 161 | PF01839 | 0.583 |
LIG_LIR_Apic_2 | 86 | 92 | PF02991 | 0.557 |
LIG_LIR_Gen_1 | 3 | 12 | PF02991 | 0.391 |
LIG_LIR_LC3C_4 | 227 | 232 | PF02991 | 0.567 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.323 |
LIG_LIR_Nem_3 | 3 | 8 | PF02991 | 0.391 |
LIG_LIR_Nem_3 | 73 | 77 | PF02991 | 0.342 |
LIG_PDZ_Class_2 | 281 | 286 | PF00595 | 0.563 |
LIG_PTB_Apo_2 | 56 | 63 | PF02174 | 0.278 |
LIG_PTB_Phospho_1 | 56 | 62 | PF10480 | 0.278 |
LIG_SH2_CRK | 167 | 171 | PF00017 | 0.655 |
LIG_SH2_CRK | 23 | 27 | PF00017 | 0.391 |
LIG_SH2_CRK | 5 | 9 | PF00017 | 0.391 |
LIG_SH2_CRK | 62 | 66 | PF00017 | 0.391 |
LIG_SH2_CRK | 89 | 93 | PF00017 | 0.576 |
LIG_SH2_GRB2like | 167 | 170 | PF00017 | 0.653 |
LIG_SH2_SRC | 167 | 170 | PF00017 | 0.653 |
LIG_SH2_STAP1 | 74 | 78 | PF00017 | 0.485 |
LIG_SH2_STAT5 | 77 | 80 | PF00017 | 0.506 |
LIG_SH3_3 | 140 | 146 | PF00018 | 0.550 |
LIG_SH3_3 | 246 | 252 | PF00018 | 0.623 |
LIG_SH3_3 | 268 | 274 | PF00018 | 0.600 |
LIG_SH3_3 | 93 | 99 | PF00018 | 0.544 |
LIG_SUMO_SIM_anti_2 | 206 | 215 | PF11976 | 0.596 |
LIG_SUMO_SIM_par_1 | 229 | 235 | PF11976 | 0.574 |
LIG_TRAF2_1 | 153 | 156 | PF00917 | 0.679 |
LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.323 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.626 |
MOD_CK1_1 | 206 | 212 | PF00069 | 0.586 |
MOD_CK1_1 | 242 | 248 | PF00069 | 0.653 |
MOD_CK1_1 | 84 | 90 | PF00069 | 0.546 |
MOD_CK2_1 | 150 | 156 | PF00069 | 0.698 |
MOD_CK2_1 | 185 | 191 | PF00069 | 0.678 |
MOD_CK2_1 | 43 | 49 | PF00069 | 0.323 |
MOD_GlcNHglycan | 118 | 121 | PF01048 | 0.560 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.366 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.678 |
MOD_GlcNHglycan | 152 | 155 | PF01048 | 0.632 |
MOD_GlcNHglycan | 241 | 244 | PF01048 | 0.701 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.690 |
MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.539 |
MOD_GlcNHglycan | 86 | 89 | PF01048 | 0.544 |
MOD_GSK3_1 | 183 | 190 | PF00069 | 0.616 |
MOD_GSK3_1 | 199 | 206 | PF00069 | 0.558 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.534 |
MOD_GSK3_1 | 239 | 246 | PF00069 | 0.694 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.338 |
MOD_N-GLC_1 | 114 | 119 | PF02516 | 0.597 |
MOD_N-GLC_1 | 38 | 43 | PF02516 | 0.391 |
MOD_N-GLC_1 | 44 | 49 | PF02516 | 0.334 |
MOD_N-GLC_1 | 84 | 89 | PF02516 | 0.566 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.621 |
MOD_PIKK_1 | 12 | 18 | PF00454 | 0.391 |
MOD_Plk_1 | 114 | 120 | PF00069 | 0.603 |
MOD_Plk_1 | 38 | 44 | PF00069 | 0.391 |
MOD_Plk_1 | 84 | 90 | PF00069 | 0.575 |
MOD_Plk_4 | 206 | 212 | PF00069 | 0.602 |
MOD_ProDKin_1 | 196 | 202 | PF00069 | 0.672 |
MOD_ProDKin_1 | 245 | 251 | PF00069 | 0.674 |
TRG_DiLeu_BaLyEn_6 | 22 | 27 | PF01217 | 0.391 |
TRG_ENDOCYTIC_2 | 23 | 26 | PF00928 | 0.391 |
TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.455 |
TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.391 |
TRG_ER_diArg_1 | 23 | 25 | PF00400 | 0.450 |
TRG_ER_diArg_1 | 274 | 276 | PF00400 | 0.602 |
TRG_ER_diArg_1 | 95 | 98 | PF00400 | 0.654 |
TRG_Pf-PMV_PEXEL_1 | 278 | 282 | PF00026 | 0.601 |
TRG_Pf-PMV_PEXEL_1 | 48 | 52 | PF00026 | 0.369 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7WQB1 | Leishmania donovani | 82% | 97% |
A4H5G3 | Leishmania braziliensis | 55% | 94% |
A4HTL3 | Leishmania infantum | 82% | 97% |
E9AME4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 99% |